PCAFX
Price
$21.90
Change
-$0.53 (-2.36%)
Updated
Dec 18 closing price
RIDAX
Price
$24.08
Change
-$0.53 (-2.15%)
Updated
Dec 18 closing price
Ad is loading...

PCAFX vs RIDAX

Header iconPCAFX vs RIDAX Comparison
Open Charts PCAFX vs RIDAXBanner chart's image
Prospector Capital Appreciation
Price$21.90
Change-$0.53 (-2.36%)
VolumeN/A
CapitalizationN/A
American Funds Income Fund of Amer R1
Price$24.08
Change-$0.53 (-2.15%)
VolumeN/A
CapitalizationN/A
PCAFX vs RIDAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PCAFX vs. RIDAX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PCAFX is a Hold and RIDAX is a Buy.

FUNDAMENTALS
Fundamentals
RIDAX has more cash in the bank: 126B vs. PCAFX (42.8M). RIDAX pays higher dividends than PCAFX: RIDAX (2.82) vs PCAFX (0.48). PCAFX was incepted earlier than RIDAX: PCAFX (17 years) vs RIDAX (23 years). PCAFX (41.00) and RIDAX (40.00) have comparable annual turnover. RIDAX has a lower initial minimum investment than PCAFX: RIDAX (250) vs PCAFX (10000). RIDAX annual gain was more profitable for investors over the last year : 10.05 vs. PCAFX (9.32). PCAFX return over 5 years is better than : 22.22 vs. RIDAX (17.26).
PCAFXRIDAXPCAFX / RIDAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence17 years23 years-
Gain YTD8.3238.72195%
Front LoadN/AN/A-
Min. Initial Investment100002504,000%
Min. Initial Investment IRAN/AN/A-
Net Assets42.8M126B0%
Annual Yield % from dividends0.482.8217%
Returns for 1 year9.3210.0593%
Returns for 3 years9.844.51218%
Returns for 5 years22.2217.26129%
Returns for 10 years33.5028.11119%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OPK1.610.01
+0.62%
OPKO Health
PFG77.54-1.13
-1.44%
Principal Financial Group
HI30.81-0.69
-2.19%
Hillenbrand
VRA3.88-0.10
-2.51%
Vera Bradley
BTAI0.39-0.02
-4.01%
BioXcel Therapeutics